BioGaia sees sales grow 22%16 Feb 2015
Probiotics company BioGaia has announced its full-year financial results. “A sales growth of 22% (including licence revenue from Nestlé 53 %) and an operating margin of 26% for the full year 2014, can only be summed up as a successful year,” said Peter Rothschild, CEO of BioGaia. “The fourth quarter showed even better growth than […]
“A sales growth of 22% (including licence revenue from Nestlé 53 %) and an operating margin of 26% for the full year 2014, can only be summed up as a successful year,” said Peter Rothschild, CEO of BioGaia. “The fourth quarter showed even better growth than the full year and it is once again gratifying to see that almost all of our markets are growing at a solid pace and that the BioGaia brand is becoming increasingly established, particularly among paediatricians, as the safest and most effective probiotic on the market.”
Full year 2014
(Figures in brackets refer to the same period of last year)
- Net sales amounted to SEK 481.8 million (315.9), an increase of SEK 165.9 million (53 %). Net sales include license revenue of SEK 95.4 million from Nestlé. Excluding license revenue from Nestlé, net sales totalled SEK 386.4 million, an increase of 22% (excluding foreign exchange effects, 18%).
- Net sales in the Paediatrics Business Unit reached SEK 313.7¹ million (238.6), up by SEK 75.1 million (31%).
- Net sales in the Adult Health Business Unit amounted to SEK 69.4 million (75.6), a decrease of SEK 6.2 million (-8%).
- Operating profit was SEK 196.9 million (81.7), an increase of SEK 115.2 million (141%). Excluding license revenue from Nestlé, operating profit was SEK 101.5 million, an increase of 24% (excluding foreign exchange effects and operating expenses for the subsidiary IBT, 21%).
- Profit after tax was SEK 148.0 million (64.2), up by SEK 83.8 million (130%). Excluding license revenue from Nestlé, profit after tax was SEK 73.6 million, an increase of 15%.
Fourth quarter 2014
- Net sales reached SEK 121.4 million (90.2), an increase of SEK 31.2 million (35%) (excluding foreign exchange effects, 28%).
- Net sales in the Paediatrics Business Unit totalled SEK 97.8 million (65.6), an improvement of SEK 32.2 million (49%).
- Net sales in the Adult Health Business Unit amounted to SEK 23.0 million (24.1), a decrease of SEK 1.1 million (-4%).
- Operating profit was SEK 30.6 million (23.8), an increase of SEK 6.8 million (29 %) (excluding foreign exchange effects and operating expenses for the subsidiary IBT, 23%).
- Profit after tax was SEK 19.1 million (16.3), an improvement of SEK 2.8 million (17%).
Digital innovations and holistic health in the Chinese market
13 Jun 2023
Health and wellness consumers in China are much younger than in the West, according to industry experts who say a tendency to act preventatively rather than reactively, coupled with a digital-first culture, gives brands an opportunity to retain consume...Read more
Brands must ‘do better’ to meet maternal nutrition needs
6 Jun 2023
Brands in the health and nutraceutical space must work harder to overcome common challenges and meet the nutritional needs of pregnant and post-natal women, says Caroline Munari, global R&D platform lead for maternal nutrition at Nestlé's sp...Read more
Most categories trading down in US supplements market, says SPINS
5 Jun 2023
Hit by the cost-of-living crisis, sales of most US vitamin and mineral supplements have declined – with the exception of probiotics, digestive aids, and homoeopathic medicines, according to SPINS data.Read more
Should brands make healthy products more affordable?
17 May 2023
Do health and wellness products need to be affordable or are consumers willing to pay a premium for a health benefit despite the cost-of-living crisis? We asked two leading market experts – and received different answers.Read more
Health innovation takes centre stage at Vitafoods Europe
26 Apr 2023
In just two weeks, Vitafoods Europe will showcase the biggest nutraceutical innovations, trends, and startups thanks to its conference programme with expert speakers, Future of Nutrition Summit, and Startup Innovation Challenge.Read more
Redefining brand value: Empower consumers to be resourceful and creative in the face of rising costs [Interview]
16 Nov 2022
With inflation, greater instability, and supply chain disruptions as a global backdrop of 2022, consumers are increasing looking for value, products with functional benefits, and convenience for the coming year, says Innova Market Insights.Read more
MicroThermics’ Formulators Guide to Process Selection for Plant-Based Beverages
15 Nov 2022
Plant-based beverages & products are mainstream! Come to FIE booth 4D122 & read our whitepaper to see how processing in the lab at commercial HTST & UHT conditions gets you to market faster for less!Read more
Affordability, indulgence, and health: Top trends for 2023 [Interview]
14 Nov 2022
Consumers want affordable alternatives that offer the same great taste and health benefits as their favourite products. Brands that can deliver on this will dominate in 2023, according to Mintel.In the food and beverage space, consumers are key in driv...Read more
Give your fermented protein drinks a clear head start
10 Nov 2022
Fermented protein beverages are rising in popularity as more consumers make efforts to strengthen their health and wellbeing. Made for the ready-to-drink segment, products such as kombucha and drinking yoghurt are gaining traction as healthier alternat...Read more
Red Bull’s ex-head of marketing shares strategies for social branding success [Interview]
21 Oct 2022
Ex-head of marketing at Red Bull Europe and current CEO of energy drink TENZING, Huib van Bockel, shares his top tips for cutting through the marketing noise and creating a socially relevant brand.Read more